Comunicati Stampa
Salute e Benessere

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24 Minutes

By cutting genome analysis from days to minutes, GOAST v4.0 empowers researchers, clinicians, and pharma companies to accelerate precision medicine, cancer research, drug discovery, and national health programs. Delivering GPU-level performance on optimized CPUs at up to 50% lower cost, GOAST makes high-throughput genomics accessible to institutions of all sizes through Lenovo's pay-as-you-go High-Performance Computing (HPC)-as-a-Service model, TruScale. By cutting genome analysis from days to...
SINGAPORE, (informazione.news - comunicati stampa - salute e benessere)

By cutting genome analysis from days to minutes, GOAST v4.0 empowers researchers, clinicians, and pharma companies to accelerate precision medicine, cancer research, drug discovery, and national health programs. Delivering GPU-level performance on optimized CPUs at up to  , GOAST makes high-throughput genomics accessible to institutions of all sizes through Lenovo's pay-as-you-go High-Performance Computing (HPC)-as-a-Service model, TruScale.

said 

GOAST is already in use at leading institutes worldwide, including the ) and , Novo Genomics ( Saudi Arabia ), and the . A leading children's hospital in is deploying GOAST to scale its genomics research, while pharma companies in the are investing in high-performance computing, pointing to growing opportunities for GOAST in new markets. In India , multiple pharma companies are using GOAST to optimize cancer research, accelerate drug discovery, and improve treatments, showcasing its transformative impact across the healthcare ecosystem.

Beyond genomics acceleration, GOAST also demonstrates how AI and HPC together are enabling downstream innovations, from smarter algorithm design to more precise bioinformatics workflows, further strengthening its role as a platform for next-generation precision health.

Lenovo's unique advantage lies in its ability to bring healthcare experts, scientists, and medical researchers together with HPC hardware and software engineers, creating multi-layered platforms like GOAST that deliver both speed and scientific depth, all focused on solving humanity's greatest challenges.

As part of Lenovo's vision, GOAST v4.0 combines the best of HPC and AI to accelerate scientific breakthroughs, making genomics research faster, more cost-effective, and globally accessible.

   

Lenovo is a US$69 billion revenue global technology powerhouse, ranked #196 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world's largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo's continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub. 

LENOVO, THINKSYSTEM, THINKEDGE, XCLARITY and RUSCALE are trademarks of Lenovo. ©2025, Lenovo Group Limited. All rights reserved. 

Photo: https://mma.prnewswire.com/media/2777162/Genomics_GOAST.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/lenovo-goast-4-0-decodes-trillions-of-cells-accelerating-genome-analysis-to-24-minutes-302561382.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili